Niagara Falls, NY, June 26, 2024 - In an exciting development, Positron Corporation (Positron), a prominent player in the molecular imaging medical device industry, has announced its acquisition of five cutting-edge NeuSight PET-CT 64 slice scanners. These advanced scanners have been ordered from Shenyang Intelligent Neuclear Medical Technology Co. a subsidiary of Neusoft Medical Systems.
Positron has solidified its position as a leading provider of Positron Emission Tomography and Computed Tomography (PET-CT) imaging systems and clinical services with this latest procurement. As medical professionals increasingly rely on PET-CT imaging for accurate diagnoses and efficient treatments, Positron’s investment in the NeuSight scanners demonstrates their commitment to delivering state-of-the-art equipment to the US market.
The NeuSight PET-CT 64 slice scanners are renowned for their exceptional imaging precision and remarkable diagnostic capabilities. By combining PET and CT technologies, these scanners provide a comprehensive view of patients’ anatomical structures, allowing physicians to detect minute abnormalities that might otherwise go unnoticed. Furthermore, the 64 slice capability ensures faster scan times, optimizing patient throughput while maintaining superior image quality.
Positron’s strategic partnership with Shenyang Intelligent Neuclear Medical Technology Co. a subsidiary of Neusoft Medical Systems, has been instrumental in facilitating this momentous investment. Known for their expertise in cutting-edge medical imaging solutions, Neusoft has consistently developed industry-leading devices that empower healthcare professionals to deliver superior patient care.
This substantial procurement aligns with Positron’s overall mission of revolutionizing the field of molecular imaging. The company aims to provide healthcare institutions and professionals with the tools necessary to improve patient outcomes, accelerate diagnoses, and enhance overall healthcare efficiency. With the addition of the NeuSight PET-CT scanners, Positron is poised to establish new benchmarks for excellence and innovation in the US medical imaging market.
In conclusion, Positron Corporation has made a significant stride in bolstering its offerings with the acquisition of five NeuSight PET-CT 64 slice scanners. This development underscores Positron’s commitment to staying at the forefront of cutting-edge medical imaging technology. With these top-of-the-line scanners, Positron is well-equipped to serve healthcare providers across the US, ultimately advancing the field of molecular imaging and shaping the future of healthcare.
Comments